TrialJAMA2014

Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial.

F Stephen Hodi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.